Default object view. Click to create a custom template, Node ID: 169118, Object ID: 101408

Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized,...

Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial

No relation

Yes

No relation

No

22/12/2016 2:37 pm

No